2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Neoplasms, Gonadal Tissue: new trials by email Literature Review of Neoplasms, Gonadal Tissue trials Research Report on Neoplasms, Gonadal Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study. Orteronel 300mg BID - Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors | Phase 2 | Terminated | Grupo Español de Tumores Huérfanos e Infrecuentes | 10 | 2014-06-01 | 2018-03-05 |
| Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary Ketoconazole - Granulosa Cell Tumour of the Ovary | Phase 2 | Terminated | Grupo Español de Tumores Huérfanos e Infrecuentes | 6 | 2012-10-01 | 2015-01-21 |
Granulosa Cell Tumor (2) · Neoplasm Metastasis (1)
Adnexal Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Ovarian Diseases (2) · Ovarian Neoplasms (2)
BID protein, human (1) · Ketoconazole (1) · orteronel (1)
Grupo Español de Tumores Huérfanos e Infrecuentes (2)
Spain (2)
Alicia Hurtado, MD (1) · Ana Santaballa, MD (1) · Isabel Bover, MD (1) · Jesus Garcia-Donas, MD (1) · Juan Cueva, MD (1) · Laia Garrigos, MD (1) · Nuria Lainez, MD (1)